Description
The anti-KMT2D (ALSPVIPLI) TCR Jurkat cell line is a stable cell line made from the anti-KMT2D TCR lentivirus. The recombinant Jurkat T cell was designed to predict the MOA of KMT2D-TCR, measure the KMT2D-TCR specificity and screen target cells expressing KMT2D. And the product can be used to treat cytomegalovirus infection